लोड हो रहा है...

Advertisement

Nektar, Cellular Biomedicine Enter New Clinical Study Collaboration

RTTNews | 702 दिनों पहले

Nektar, Cellular Biomedicine Enter New Clinical Study Collaboration

(RTTNews) - Nektar Therapeutics (NKTR) announced Wednesday that it has entered into a new clinical study collaboration with Cellular Biomedicine Group Inc. (CBMG).

The study will evaluate Nektar's NKTR-255, a novel interleukin-15 (IL-15) receptor agonist, in combination with CBMG's C-TIL051, a tumor-infiltrating lymphocyte (TIL) therapy, in advanced non-small cell lung cancer (NSCLC) patients that are relapsed or refractory to anti-PD-1 therapy.

Preclinical and early clinical data suggest that IL-15 can improve proliferation and persistence of cellular therapies including TIL, TCR, and CAR-T therapies to increase specific anti-tumor activity.

Under the new collaboration, CBMG will add NKTR-255 to its ongoing CBMG-sponsored Phase 1 clinical trial evaluating C-TIL051 in NSCLC patients who have relapsed on or were refractory to anti-PD-1 therapy.

The study is expected to enroll a total of 20 patients. Nektar will contribute NKTR-255 supply for the study. Nektar and CBMG will each maintain existing global rights to their respective investigational medicines.

For More Such Health News, visit rttnews.com

टैग: NKTR CBMG

read more

Nektar Therapeutics Promotes Chief Accounting Officer Jillian Thomsen To CFO

Nektar Therapeutics Promotes Chief Accounting Officer Jillian Thomsen To CFO

Nektar Therapeutics (NKTR) announced Friday the promotion of Jillian Thomsen to Senior Vice President (SVP) & Chief Financial Officer. Thomsen has served as SVP, Finance & Chief Accounting Officer of Nektar since 2008, and is a key member of the Executive Committee.

RTTNews | 1155 दिनों पहले

FTSE 100 Weak Again, Looks Headed For Weekly Loss

FTSE 100 Weak Again, Looks Headed For Weekly Loss

U.K. stocks are trading lower on Friday, losing ground for a fourth straight session, weighed down to a large extent by the weakness in the financial sector, amid reports of likely imposition of windfall tax on banks.

RTTNews | 30 मिनटों पहले

Pound Falls Against Majors

Pound Falls Against Majors

The British pound weakened against other major currencies in the European session on Friday.

RTTNews | 38 मिनटों पहले

French Stocks Mostly Subdued In Cautious Trade

French Stocks Mostly Subdued In Cautious Trade

The French market is down in negative territory on Friday with investors digesting a slew of economic data, and look ahead to key consumer inflation report from the U.S.

RTTNews | 49 मिनटों पहले

French Inflation Cools; Economy Expands As Estimated

French Inflation Cools; Economy Expands As Estimated

France's consumer price inflation softened in August on weaker growth in transport costs and the economy logged a faster growth as estimated in the second quarter, official data revealed Friday. Consumer price inflation weakened marginally to 0.9 percent in August from 1.0 percent in July, provisional data from the statistical office INSEE showed.

RTTNews | 1घंटे 15 मिनट पहले

Sensex, Nifty Extend Losses On Trade Worries

Sensex, Nifty Extend Losses On Trade Worries

Indian shares ended lower on Friday to extend recent declines due to concerns over steep U.S. tariffs imposed on Indian goods.

RTTNews | 1घंटे 15 मिनट पहले

DAX Down Nearly 0.5% As Investors Focus On Economic Data

DAX Down Nearly 0.5% As Investors Focus On Economic Data

German stocks are down in negative territory in cautious trade on Friday as investors digest the nation's import prices and retail sales data and await U.S. inflation data due later in the day,

RTTNews | 1घंटे 23 मिनट पहले

European Shares Drift Lower Ahead Of US Inflation Reading

European Shares Drift Lower Ahead Of US Inflation Reading

European stocks traded lower on Friday as investors waited for key U.S. inflation data due later in the day that could provide additional clues on a potential Federal Reserve rate cut in September.

RTTNews | 2घंटे 44 मिनट पहले

शर्तें | गोलनीयता | साइट का मैप | Site Map Calendar

&प्रतिलिपि; 2025 Myfxbook Ltd. सर्वाधिकार सुरक्षित.

उच्च जोखिम चेतावनी: फॉरन एक्सचेंज ट्रेडिंग में उच्च स्तर का खतरा होता है जो हर निवेशकों के लिए सही नहीं हो सकता. लीवरेज अधिकतम खातर और हानि के अनावरण को उत्पन्न करता है. इससे पहले कि आप निर्णय लें फॉरन एक्सचेंज में ट्रेड करने का, ध्यान अपने निवेश के उद्देश्यों, अनुभव स्तर, और खतरा उठाने की सहिष्णुता पर विचार करें. आप कुछ या अपनी प्रारंभिक निवेश को खो सकते हैं. बिल्कुल भी उस पैसे को निवेश ना करें जो आप खोने को बर्दाश्त नहीं कर सकते. अपने आप को शिक्षित करें उन खतरों से जो फॉरन एक्सचेंज ट्रेडिंग से संबंधित हैं, और सलाह लें किसी स्वतंत्र आर्थिक या कर सलाहकार से अगर आपके पास कोई भी प्रश्न हैं तो. कोई भी डाटा या जानकारों जो दी जाती है वे केवल सूचनात्मक उद्देश्यों के लिए है, और यब ट्रेडिंग आशय या सलाह पर नियत नहीं है. पिछले निष्पादन भविष्य के परिणामों के लिए परियाचक नहीं हैं.